FARN — Faron Pharmaceuticals Oy Share News
0.000.00%
Last trade - 00:00- £203.10m
- £210.89m
REG - Faron Pharma. Oy - Notice of Financial Statement and Annual Report
AnnouncementREG - Faron Pharma. Oy - Holding(s) in Company
AnnouncementREG - Faron Pharma. Oy - Change of Broker
AnnouncementREG - Faron Pharma. Oy - Holding(s) in Company
AnnouncementREG - Faron Pharma. Oy - Results of Oversubscribed Placing
AnnouncementREG - Faron Pharma. Oy - Proposed Issue and Placing
AnnouncementRCS - Faron Pharma. Oy - Final Patient Identified for BEXMAB Phase II Study
AnnouncementREG - Faron Pharma. Oy - Faron’s Financial Calendar for 2025
AnnouncementRCS - Faron Pharma. Oy - Faron presents BEXMAB data at ASH Annual Meeting
AnnouncementRCS - Faron Pharma. Oy - Interactions with UK Regulatory Authorities
AnnouncementREG - Faron Pharma. Oy - Positive Phase 2 Interim Results from BEXMAB Trial
AnnouncementRCS - Faron Pharma. Oy - Targeting Soluble Clever-1 for Autoimmune Diseases
AnnouncementREG - Faron Pharma. Oy - Shareholders’ Nomination Board
AnnouncementREG - Faron Pharma. Oy - Faron’s Capital Markets Day 2024
AnnouncementRCS - Faron Pharma. Oy - Faron announces Capital Markets Day
AnnouncementREG - Faron Pharma. Oy - Grant of options
AnnouncementREG - Faron Pharma. Oy - FDA Grants Fast Track Designation for Bexmarilimab
AnnouncementREG - Faron Pharma. Oy - Faron 2024 Half-Year Financial Results
AnnouncementREG - Faron Pharma. Oy - Notice of Half-Year Financial Results
Announcement